Media
Presentations
Corporate Presentation
Download Presentation
Videos
OKYO CEO Gary Jacob talks to RedChip about the recent initiation of the Phase 2 trial for Neuropathic Corneal Pain (NCP) (Nov 2024)
OKYO CEO Gary Jacob talks to RedChip to Explain How OKYO Pharma is Targeting the Multi-Billion-Dollar Dry Eye Disease Market (Aug 2024)
OKYO Pharma provides update on development of OK-101 (June 2024)
OKYO Pharma granted new patent for OK-101 to treat neuropathic pain
OKYO Pharma reaches milestone with first patient screening for dry eye disease trial
OKYO Pharma to take dry eye disease drug direct into Phase 2 clinical trials
OKYO CEO Gary Jacob talks to Jane King about the progress of the phase 2 trial with OK-101